TLRY - Tilray Inc Stock Price, Fair Value and News

1.83USD+0.08 (+4.57%)Delayed as of 26 Apr 2024, 09:54 am ET

Market Summary

USD1.83+0.08

Delayedas of 26 Apr 2024, 09:54 am

4.57%

TLRY Alerts

Big jump in Revenue (Y/Y)

Big jump in Earnings (Y/Y)
Losses in recent quarter

TLRY Stock Price

View Fullscreen

TLRY RSI Chart

TLRY Valuation

Market Cap

1.4B

Price/Earnings (Trailing)

-3.85

Price/Sales (Trailing)

1.82

EV/EBITDA

-4.2

Price/Free Cashflow

-75.19

TLRY Price/Sales (Trailing)

TLRY Profitability

Operating Margin

86.69%

EBT Margin

-42.75%

Return on Equity

-10.53%

Return on Assets

-8.35%

Free Cashflow Yield

-1.33%

TLRY Fundamentals

TLRY Revenue

Revenue (TTM)

743.2M

Rev. Growth (Yr)

29.36%

Rev. Growth (Qtr)

-2.8%

TLRY Earnings

Earnings (TTM)

-351.9M

Earnings Growth (Yr)

92.08%

Earnings Growth (Qtr)

-89.15%

Breaking Down TLRY Revenue

52 Week Range

1.503.40

(Low)(High)

Last 7 days

1.7%

Last 30 days

-24.2%

Last 90 days

-8.4%

Trailing 12 Months

-19.7%

How does TLRY drawdown profile look like?

TLRY Financial Health

Current Ratio

1.92

Debt/Equity

0.04

Debt/Cashflow

-0.14

TLRY Investor Care

Shares Dilution (1Y)

25.25%

Diluted EPS (TTM)

-0.47

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	743.2M	0	0	0
2023	596.3M	627.1M	650.9M	700.5M
2022	617.3M	628.4M	613.6M	602.5M
2021	361.3M	370.7M	482.2M	513.4M
2020	295.7M	320.3M	333.5M	348.8M
2019	58.4M	179.3M	293.7M	281.1M
2018	23.3M	28.1M	32.7M	43.1M
2017	14.6M	16.6M	18.6M	20.5M
2016	0	0	0	12.6M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Tilray Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jan 17, 2024	faltischek denise m	bought	20,500	2.05	10,000	chief strategy officer
Jan 16, 2024	gendel mitchell	bought	14,256	1.98	7,200	global general counsel
Jan 12, 2024	gendel mitchell	bought	10,098	1.87	5,400	global general counsel
Jan 12, 2024	merton carl a	bought	37,400	1.87	20,000	chief financial officer
Jan 12, 2024	simon irwin d	bought	100,956	1.88	53,700	president and ceo
Jul 31, 2023	merton carl a	acquired	475,266	2.53	187,852	chief financial officer
Jul 31, 2023	faltischek denise m	sold (taxes)	-242,624	2.53	-95,899	chief strategy officer
Jul 31, 2023	simon irwin d	sold (taxes)	-1,976,170	2.53	-781,094	president and ceo
Jul 31, 2023	faltischek denise m	acquired	475,266	2.53	187,852	chief strategy officer
Jul 31, 2023	merton carl a	sold (taxes)	-238,394	2.53	-94,227	chief financial officer

Which funds bought or sold TLRY recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 24, 2024	Cambridge Investment Research Advisors, Inc.	reduced	-4.67	7,000	323,000	-%
Apr 24, 2024	CENTRAL TRUST Co	unchanged	-	21.00	297	-%
Apr 24, 2024	Simplicity Wealth,LLC	new	-	28,336	28,336	-%
Apr 24, 2024	GDS Wealth Management	unchanged	-	3,064	44,524	-%
Apr 24, 2024	Spire Wealth Management	unchanged	-	2,238	11,760	-%
Apr 24, 2024	PROFFITT & GOODSON INC	sold off	-100	-56.00	-	-%
Apr 24, 2024	Newbridge Financial Services Group, Inc.	added	13.87	15,143	83,101	0.04%
Apr 24, 2024	PSI Advisors, LLC	unchanged	-	6.00	82.00	-%
Apr 24, 2024	Activest Wealth Management	unchanged	-	1,700	24,700	0.01%
Apr 23, 2024	Tennessee Valley Asset Management Partners	sold off	-100	-3,439	-	-%

Are Funds Buying or Selling TLRY?

Are funds buying TLRY calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own TLRY

No. of Funds

Unveiling Tilray Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2023	hudson bay capital management lp	2.23%	14,006,029	SC 13G/A
Feb 10, 2023	hudson bay capital management lp	9.99%	68,275,295	SC 13G
May 25, 2021	kennedy brendan	2.9%	12,837,819	SC 13D/A
Feb 16, 2021	cvi investments, inc.	-	7,012,907	SC 13G/A
Feb 16, 2021	etf managers group, llc	4.08%	5,446,196	SC 13G/A
Feb 16, 2021	groh christian	229%	3,930,804	SC 13D/A
Feb 16, 2021	blue michael g.	906%	4,598,454	SC 13D/A
Feb 16, 2021	kennedy brendan	7.9%	12,782,843	SC 13D/A
Dec 07, 2020	etf managers group, llc	5.01%	6,690,462	SC 13G/A
Nov 16, 2020	etf managers group, llc	4.71%	6,282,498	SC 13G/A

Recent SEC filings of Tilray Inc

View All Filings

Date Filed	Form Type	Document
Apr 09, 2024	8-K	Current Report
Apr 09, 2024	10-Q	Quarterly Report
Feb 16, 2024	8-K	Current Report
Feb 16, 2024	424B7	Prospectus Filed
Feb 06, 2024	8-K	Current Report
Jan 19, 2024	4	Insider Trading
Jan 18, 2024	4	Insider Trading

Peers (Alternatives to Tilray Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	353.7B	85.2B	-5.73%	-9.70%	10.06	4.15	6.46%	95.94%
MRK	330.8B	60.1B	4.06%	15.15%	906.27	5.5	1.40%	-97.49%
AMGN	144.4B	28.2B	-4.38%	12.82%	21.5	5.12	7.09%	2.52%
PFE	142.6B	46.5B	-8.45%	-34.61%	-102.73	3.06	42.59%	-114.62%
GILD	81.3B	27.1B	-9.83%	-22.03%	14.36	3	-0.60%	23.36%
TEVA	14.8B	15.8B	-6.29%	61.39%	-25.76	0.94	6.17%	76.47%
MID-CAP
PRGO	4.2B	4.7B	1.56%	-13.21%	-333.67	0.91	4.58%	90.97%
ALKS	4.1B	1.7B	-8.63%	-13.78%	11.48	2.45	49.61%	324.78%
BHC	3.1B	8.8B	-12.58%	22.10%	-5.32	0.36	7.79%	-163.11%
AMPH	2.0B	644.4M	-5.53%	6.97%	14.28	3.05	29.14%	50.51%
SMALL-CAP
TLRY	1.4B	743.2M	-24.24%	-19.72%	-3.85	1.82	24.65%	80.36%
TXMD	21.6M	1.3M	-16.89%	-47.03%	-2.1	16.56	-98.14%	-109.18%
ACRX	18.8M	-	-0.89%	64.15%	-1.02	0.22	2882.68%	-138.52%
AGRX	2.7M	19.6M	21.21%	-93.94%	-0.19	0.14	80.00%	43.08%
ACOR	931.6K	117.6M	-96.48%	-95.45%	0	0.01	-0.79%	-283.60%

Tilray Inc News

Latest updates

Tilray Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2021Q1	2020Q4	2020Q4	2020Q3	2020Q3	2020Q2	2020Q2	2020Q1
Revenue	-2.8%	188,340,000	193,771,000	176,949,000	184,188,000	145,589,000	144,136,000	153,211,000	153,325,000	151,871,000	155,153,000	168,023,000	142,236,000	48,021,000	123,900,000	56,560,000	129,459,000	51,406,000	117,490,000	50,414,000	113,542,000	52,102,000
Gross Profit	4.2%	49,396,000	47,409,000	44,196,000	67,163,000	-11,699,000	42,882,000	48,614,000	-6,733,000	39,829,000	32,766,000	50,955,000	22,498,000	13,503,000	30,456,000	16,642,000	35,283,000	3,330,000	34,945,000	-5,824,000	27,807,000	10,870,000
Costs and Expenses	-100.0%	-	16,451,000	15,887,000	-2,469,000	164,498,000	15,835,000	72,934,000	25,870,000	13,509,000	936,000	26,067,000	-	-	-	-	-	-	-	-	-	-
Operating Expenses	47.5%	131,494,000	89,168,000	78,558,000	157,143,000	1,195,037,000	94,673,000	69,792,000	460,690,000	57,909,000	88,295,000	120,324,000	96,185,000	-	54,506,000	-	61,243,000	-	43,419,000	-	-	-
S&GA Expenses	31.8%	9,995,000	7,583,000	6,859,000	9,048,000	6,452,000	9,669,000	9,671,000	9,643,000	8,641,000	9,210,000	7,432,000	-	9,739,000	6,155,000	34,861,500	6,079,000	10,000,000	5,817,000	12,833,000	-	18,326,000
R&D Expenses	89.3%	106,000	56,000	79,000	180,000	171,000	165,000	166,000	54,000	164,000	515,000	785,000	-	1,202,000	127,000	3,545,500	225,000	921,000	120,000	652,000	-	1,347,000
EBITDA Margin	78.9%	-0.43	-2.02	-2.02	-2.11	-2.81	-0.69	-0.56	-0.49	-0.47	-0.57	-0.61	-0.79	-	-	-	-	-	-	-	-	-
Income Taxes	-184.9%	-2,871,000	3,380,000	7,264,000	-3,581,000	-10,811,000	11,713,000	7,211,000	-3,803,000	-1,830,000	-5,671,000	4,762,000	-	378,000	6,310,000	22,582,000	-14,192,000	243,000	-5,825,000	-39,000	-	301,000
Earnings Before Taxes	-117.6%	-107,854,000	-49,563,000	-48,599,000	-111,687,000	-1,206,563,000	-73,348,000	-58,583,000	-461,603,000	50,645,000	126,000	-29,842,000	-	-341,212,000	-252,333,000	-130,911,000	-103,441,000	-1,939,000	-27,569,000	-84,601,000	-	-185,094,000
EBT Margin	78.9%	-0.43	-2.02	-2.21	-2.31	-3.02	-0.90	-0.77	-0.70	-0.56	-0.67	-0.72	-0.93	-	-	-	-	-	-	-	-	-
Net Income	-89.2%	-92,701,000	-49,008,000	-71,525,000	-138,713,000	-1,170,998,000	-69,463,000	-73,482,000	-478,141,000	43,190,000	-201,000	-41,649,000	47,204,000	-340,955,000	-273,519,000	-2,947,000	-99,900,000	-2,316,000	-34,343,000	-81,687,000	-87,105,000	-184,123,000
Net Income Margin	76.8%	-0.47	-2.04	-2.23	-2.32	-3.01	-0.96	-0.83	-0.76	0.08	-0.72	-0.76	-0.99	-	-	-	-	-	-	-	-	-
Free Cashflow	49.5%	-15,361,000	-30,409,000	-18,308,000	41,132,000	-21,098,000	26,743,000	-48,735,000	-22,990,000	-48,856,000	-19,587,000	-95,693,000	-15,474,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q2	2020Q1	2019Q4	2019Q3
Assets	-2.7%	4,213	4,331	4,402	4,307	4,376	5,474	5,592	5,450	5,450	5,819	5,763	5,986	6,025	1,168	946	887	856	1,738	916	896	1,040
Current Assets	-1.7%	631	642	829	773	759	815	911	804	804	696	708	845	884	572	347	305	290	582	339	259	331
Cash Equivalents	2.0%	146	143	178	207	165	190	491	416	416	279	332	376	488	416	190	155	137	361	174	97.00	100
Inventory	-3.4%	244	253	232	201	203	241	245	246	246	273	233	252	256	97.00	94.00	90.00	93.00	140	96.00	88.00	110
Net PPE	-	579	-	-	430	-	-	-	587	-	-	-	-	651	198	200	188	176	-	187	184	166
Goodwill	0.0%	2,010	2,010	2,010	2,009	2,006	2,621	2,618	2,641	2,641	2,835	3.00	2,809	2,833	169	167	160	156	447	160	163	163
Liabilities	-7.2%	870	937	1,001	977	969	991	1,029	1,008	1,008	1,158	1,290	1,601	1,560	628	572	701	724	463	725	611	624
Current Liabilities	-16.7%	329	395	537	433	470	427	273	280	280	282	315	527	401	284	181	134	164	120	171	92.00	130
Short Term Borrowings	-25.5%	15.00	20.00	15.00	23.00	18.00	15.00	18.00	18.00	18.00	17.00	9.00	9.00	9.00	-	-	-	-	0.00	-	-	-
Long Term Debt	2.3%	127	124	121	221	223	223	-	402	402	121	152	165	167	-	-	-	-	94.00	-	-	-
LT Debt, Current	-35.1%	83.00	128	252	174	184	182	64.00	-	-	70.00	32.00	31.00	37.00	-	-	-	-	6.00	-	-	-
LT Debt, Non Current	-100.0%	-	124	121	221	223	223	-	402	402	121	152	165	167	-	-	-	-	94.00	-	-	-
Shareholder's Equity	-0.8%	3,343	3,368	3,402	3,316	3,404	4,483	4,563	4,441	4,399	4,661	4,473	4,386	4,465	541	374	187	131	1,275	190	285	416
Retained Earnings	-3.7%	-2,628	-2,536	-2,487	-2,415	-2,276	-1,105	-1,036	-962	-962	-484	-527	-527	-486	-1,071	-730	-727	-724	-113	-643	-430	-209
Additional Paid-In Capital	1.5%	6,031	5,943	5,910	5,778	5,723	5,697	5,641	5,382	5,382	5,111	4,955	4,796	4,792	1,600	1,096	911	856	1,367	840	706	623
Shares Outstanding	5.6%	774	733	723	657	618	612	575	533	533	486	455	449	270	-	-	-	-	-	-	-	-
Minority Interest	-163.2%	-15.82	25.00	22.00	14.00	3.00	13.00	38.00	43.00	43.00	34.00	37.00	66.00	6.00	-	-	-	-	27.00	-	-	-
Float	-	-	-	-	-	-	2,400	-	-	-	-	5.00	-	676	-	-	-	676	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2021Q1	2020Q4	2020Q4	2020Q3	2020Q3	2020Q2	2020Q2	2020Q1
Cashflow From Operations	49.5%	-15,361	-30,409	-15,842	43,598	-18,632	29,209	-46,269	-20,524	-46,390	-17,121	-93,227	-	-13,008	-	-19,589	-	-	-56,100	-	-	-54,031
Share Based Compensation	-1.7%	8,059	8,201	8,257	9,829	9,630	10,943	9,193	8,969	9,355	13,596	4,074	-	7,193	-	18,527	259	8,080	2,850	7,647	-	7,677
Cashflow From Investing	-65.5%	28,086	81,497	-26,290	-7,584	-4,592	-271,398	-1,537	-4,915	-1,026	-6,972	-8,620	-	-69.00	-	266,588	-	-	-13,698	-	-	-18,119
Cashflow From Financing	87.2%	-10,909	-85,366	14,018	6,236	-2,442	-57,256	123,620	161,808	-5,565	-20,019	-8,028	-	234,081	-	152,172	-	-	6,737	-	-	159,786

TLRY Income Statement

2024-02-29

Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Net revenue	$ 188,340	$ 145,589	$ 559,060	$ 442,936
Cost of goods sold	138,944	157,288	418,059	363,139
Gross profit (loss)	49,396	(11,699)	141,001	79,797
Operating expenses:
General and administrative	39,940	38,999	123,769	117,385
Selling	9,995	6,452	24,437	25,792
Amortization	21,558	23,518	65,700	71,872
Marketing and promotion	11,191	7,354	28,934	23,137
Research and development	106	171	241	502
Change in fair value of contingent consideration	(5,983)	352	(16,790)	563
Impairments	0	934,000	0	934,000
Other than temporary change in fair value of convertible notes receivable	42,681	181,376	42,681	181,376
Litigation costs, net of recoveries	3,363	(5,230)	8,439	(1,970)
Restructuring costs	5,178	2,663	8,748	10,727
Transaction costs (income)	3,465	5,382	13,061	(3,882)
Total operating expenses	131,494	1,195,037	299,220	1,359,502
Operating loss	(82,098)	(1,206,736)	(158,219)	(1,279,705)
Interest expense, net	(8,517)	(1,040)	(26,977)	(8,560)
Non-operating income (expense), net	(17,239)	1,213	(20,820)	(50,229)
Loss before income taxes	(107,854)	(1,206,563)	(206,016)	(1,338,494)
Income tax (recovery) expense	(2,871)	(10,811)	1,013	(15,313)
Net loss	(104,983)	(1,195,752)	(207,029)	(1,323,181)
Total net income (loss) attributable to:
Stockholders of Tilray Brands, Inc.	(92,701)	(1,170,998)	(213,234)	(1,313,943)
Non-controlling interests	(12,282)	(24,754)	6,205	(9,238)
Other comprehensive gain (loss), net of tax
Foreign currency translation gain (loss)	(4,696)	6,390	3,716	(78,499)
Unrealized gain (loss) on convertible notes receivable	0	95,345	0	75,177
Total other comprehensive gain (loss), net of tax	(4,696)	101,735	3,716	(3,322)
Comprehensive loss	(109,679)	(1,094,017)	(203,313)	(1,326,503)
Total comprehensive income (loss) attributable to:
Stockholders of Tilray Brands, Inc.	(97,521)	(1,092,491)	(209,811)	(1,336,127)
Non-controlling interests	$ (12,158)	$ (1,526)	$ 6,498	$ 9,624
Weighted average number of common shares - basic (in shares)	754,439,331	615,534,670	725,346,952	597,829,714
Weighted average number of common shares - diluted (in shares)	754,439,331	615,534,670	725,346,952	597,829,714
Net loss per share - basic (in dollars per share)	$ (0.12)	$ (1.9)	$ (0.29)	$ (2.2)
Net loss per share - diluted (in dollars per share)	$ (0.12)	$ (1.9)	$ (0.29)	$ (2.2)

TLRY Balance Sheet

2024-02-29

Consolidated Statements of Financial Position (Current Period Unaudited) - USD ($) $ in Thousands	Feb. 29, 2024	May 31, 2023
Current assets
Cash and cash equivalents	$ 146,253	$ 206,632
Marketable securities	79,605	241,897
Accounts receivable, net	89,542	86,227
Inventory	244,139	200,551
Prepaids and other current assets	43,034	37,722
Assets held for sale	28,638	0
Total current assets	631,211	773,029
Capital assets	578,783	429,667
Operating lease, right-of-use assets	17,453	5,941
Intangible assets	930,105	973,785
Goodwill	2,009,632	2,008,843
Interest in equity investees	0	4,576
Long-term investments	8,058	7,795
Convertible notes receivable	32,000	103,401
Other assets	5,614	222
Total assets	4,212,856	4,307,259
Current liabilities
Bank indebtedness	15,029	23,381
Accounts payable and accrued liabilities	209,763	190,682
Contingent consideration	0	16,218
Warrant liability	3,182	1,817
Current portion of lease liabilities	5,424	2,423
Current portion of long-term debt	12,351	24,080
Current portion of convertible debentures payable	83,351	174,378
Total current liabilities	329,100	432,979
Long - term liabilities
Contingent consideration	14,000	10,889
Lease liabilities	73,228	7,936
Long-term debt	165,648	136,889
Convertible debentures payable	126,587	221,044
Deferred tax liabilities, net	161,042	167,364
Other liabilities	210	215
Total liabilities	869,815	977,316
Commitments and contingencies (refer to Note 19)
Stockholders' equity
Common stock ($0.0001 par value; 1,198,000,000 common shares authorized; 774,028,053 and 656,655,455 common shares issued and outstanding, respectively)	77	66
Preferred shares ($0.0001 par value; 10,000,000 preferred shares authorized; nil and nil preferred shares issued and outstanding, respectively)	0	0
Additional paid-in capital	6,030,709	5,777,743
Accumulated other comprehensive loss	(43,187)	(46,610)
Accumulated Deficit	(2,628,741)	(2,415,507)
Total Tilray Brands, Inc. stockholders' equity	3,358,858	3,315,692
Non-controlling interests	(15,817)	14,251
Total stockholders' equity	3,343,041	3,329,943
Total liabilities and stockholders' equity	$ 4,212,856	$ 4,307,259

About Tilray Inc

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

CEO	Mr. Irwin David Simon
WEBSITE	tilray.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	1600

Tilray Inc Frequently Asked Questions

What is the ticker symbol for Tilray Inc? What does TLRY stand for in stocks?

TLRY is the stock ticker symbol of Tilray Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Tilray Inc (TLRY)?

As of Thu Apr 25 2024, market cap of Tilray Inc is 1.35 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TLRY stock?

You can check TLRY's fair value in chart for subscribers.

What is the fair value of TLRY stock?

You can check TLRY's fair value in chart for subscribers. The fair value of Tilray Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Tilray Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TLRY so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Tilray Inc a good stock to buy?

The fair value guage provides a quick view whether TLRY is over valued or under valued. Whether Tilray Inc is cheap or expensive depends on the assumptions which impact Tilray Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TLRY.

What is Tilray Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 25 2024, TLRY's PE ratio (Price to Earnings) is -3.85 and Price to Sales (PS) ratio is 1.82. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TLRY PE ratio will change depending on the future growth rate expectations of investors.